AR-A014418, GSK-3 inhibitor

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

Interferon beta (IFN-β) and GSK-3 beta are important proteins with distinct mechanical roles in cellular functions. Interferon beta is a cytokine involved in immune response aiding in defense against viral infections. It has a molecular mass of approximately 20 kDa and is expressed in various cells especially immune cells like macrophages and dendritic cells. GSK-3 beta also known as glycogen synthase kinase 3 beta is a serine/threonine kinase enzyme with a molecular weight of about 46 kDa. This kinase is mainly expressed in the brain but also found in other tissues.

Biological function summary

The functions of interferon beta extend to modulating the activity of immune cells enhancing the expression of major histocompatibility complex molecules and inhibiting viral replication. It acts as a bridge between innate and adaptive immunity. GSK-3 beta influences several biological processes including glycogen metabolism cellular proliferation and apoptosis. It does not function in isolation but forms part of larger signaling complexes significantly impacting cellular responses and development.

Pathways

Both interferon beta and GSK-3 beta play pivotal roles in different biochemical pathways. Interferon beta is part of the JAK-STAT signaling pathway which is important for transmitting information from extracellular cytokines to the nucleus thereby regulating gene expression. GSK-3 beta participates in the Wnt signaling pathway which is integral in cell fate determination and embryonic development. Interactions within these pathways connect GSK-3 beta with proteins such as beta-catenin and AKT whereas interferon beta influences JAK kinases and STAT proteins.

Alterations in interferon beta levels relate to multiple sclerosis where it is used as a treatment to manage symptoms and slow disease progression. Imbalance in GSK-3 beta activity associates with Alzheimer's disease contributing to tau phosphorylation and neurodegeneration. These proteins' roles in these conditions highlight their potential as therapeutic targets with interferon beta impacting immune signaling and GSK-3 beta connecting to kinases involved in phosphorylation cascades.